Last reviewed · How we verify

NCT07352150

Undiluted and Diluted Nutrition

Not yet recruiting NA Last updated 20 January 2026
What this trial tests

NA trial testing Enteral fluid in Critical Illness in 80 participants. Not yet recruiting.

Timeline
2 February 2026
Primary endpoint
30 June 2027
30 September 2027

Quick facts

Lead sponsorJohn Paul II Catholic University of Lublin
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment80
Start date2 February 2026
Primary completion30 June 2027
Estimated completion30 September 2027
Sites2 locations across Poland

Drugs / interventions tested

Conditions studied

Sponsor

John Paul II Catholic University of Lublin

Who can join

18 and older, any sex, with Critical Illness or Gastro Intestinal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adult patients after elective major abdominal surgeries who are planned to be admitted to the Intensive Care Unit (ICU) can be included in the trial. Each patient will be fed via the gastrointestinal tract. Half of the patients will receive enteral nutrition (EN) with additional fluids, and the rest will receive undiluted EN. The primary aim of this study is to assess feeding intolerance in both patient groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Enteral fluid

Trials testing the same drug.

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07352150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing